JNGLX Mutual Fund (Janus Henderson Global Life Sciences Fund Class D) is managed by Janus Henderson Investors with $1.45B in net assets. JNGLX expense ratio is 0.81%, holding 109 positions across sectors including Health Care, Unknown, Other. Inception date: 1998-12-31.

JNGLX performance shows a YTD return of 8.54%. The 1-year return is 39.50% and the 5-year return is 8.52%. JNGLX dividend yield stands at 4.20%, paid annually.

JNGLX top holdings include Eli Lilly And Company (9.7%), JOHNSON AND JOHNSON (5.6%), Astrazeneca Plc Adr (4.3%), Unitedhealth Group, Inc. (3.4%), Abbvie Inc Health Care (3.4%). View all JNGLX holdings, sector breakdown, or dividend history.

JNGLX can be compared against other funds using the overlap calculator or side-by-side comparison tool. JNGLX alternatives are available via the screener, along with tax-loss harvesting opportunities.